{"transactions":[{"id":1672963,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-01-23T16:23:11.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on January 22, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on April 1, 2025."}],"balance_after":285000,"derivative":{"exercise_price":2.79,"expiration_date":"2034-01-21","underlying":"Common Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001235802-24-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000123580224000015/primary_doc.xml","form_type":"4"}},{"id":1973072,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T09:05:53.000Z","date":"2023-03-02","kind":"grant","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":10.8,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-23-000059","document":"wf-form4_167785233655513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550823000059/wf-form4_167785233655513.xml","form_type":"4"}},{"id":1973071,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T09:05:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration. The number of shares disposed of reflects 2,000 shares of Common Stock upon the acceleration of vesting of restricted stock units in accordance with the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001385508-23-000059","document":"wf-form4_167785233655513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550823000059/wf-form4_167785233655513.xml","form_type":"4"}},{"id":1973070,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T09:05:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Indivior Inc., and Olive Acquisition Subsidiary, Inc., dated as of November 13, 2022 (the \"Merger Agreement\"), in exchange for a cash payment of $20.00 per share without interest thereon (the \"Merger Consideration\")."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-23-000059","document":"wf-form4_167785233655513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550823000059/wf-form4_167785233655513.xml","form_type":"4"}},{"id":2232590,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T16:55:58.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"shares","element":"transactionShares","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001385508-22-000086","document":"wf-form4_165524014507774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550822000086/wf-form4_165524014507774.xml","form_type":"4"}},{"id":2666212,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T16:04:18.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-21-000084","document":"wf-form4_162387383591827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550821000084/wf-form4_162387383591827.xml","form_type":"4"}},{"id":2776203,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-22T16:10:21.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on March 18, 2022 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5000,"derivative":{"exercise_price":10.8,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-21-000052","document":"wf-form4_161644379924757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000138550821000052/wf-form4_161644379924757.xml","form_type":"4"}},{"id":3430150,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-08-23T16:05:19.000Z","date":"2019-08-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest monthly in 36 equal installments beginning 8/31/19."}],"balance_after":60000,"derivative":{"exercise_price":1.12,"expiration_date":"2029-08-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-19-047144","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000110465919047144/a4.xml","form_type":"4"}},{"id":3626254,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-02-28T19:00:02.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"11,111 options to purchase shares of common stock vest immediately on 2/26/19.  The remainder vest in 34 equal monthly installments commencing 3/1/2019."}],"balance_after":200000,"derivative":{"exercise_price":3.96,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-19-011640","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000110465919011640/a4.xml","form_type":"4"}},{"id":4137901,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":94990,"kind":"person","name":"Lorianne Masuoka K.","position":1,"cik":"0001466086","reported_name":"Lorianne Masuoka K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2017-12-08T16:06:11.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/1/2018."}],"balance_after":150000,"derivative":{"exercise_price":6.19,"expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-17-072520","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466086/000110465917072520/a4.xml","form_type":"4"}}]}